These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5241095)

  • 1. Clinical precision in therapy for coagulation disorders.
    Rosenthal MC
    N Y State J Med; 1968 Jun; 68(12):1695-8. PubMed ID: 5241095
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulation factors. Indications and applications].
    Stampfli K; Hartmann S
    Ther Umsch; 1984 Aug; 41(8):571-5. PubMed ID: 6437000
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dental surgery in the coagulopathic patient. 4. General therapy of hemorrhagic diseases].
    Nardi P; Grandini R; Bertolai R
    G Stomatol Ortognatodonzia; 1989; 8(2):25-8. PubMed ID: 2534997
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma fractionation with special reference to the treatment of coagulation disorders.
    Bidwell E
    Proc R Soc Med; 1968 Jun; 61(6):598-600. PubMed ID: 5662213
    [No Abstract]   [Full Text] [Related]  

  • 6. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
    Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemofil and other factor VIII concentrates.
    Med Lett Drugs Ther; 1969 Nov; 11(23):96. PubMed ID: 5375104
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasma and plasma fractions in the therapy of blood coagulation disorders].
    Lechler E
    Internist (Berl); 1974 Sep; 15(9):461-4. PubMed ID: 4609113
    [No Abstract]   [Full Text] [Related]  

  • 9. A simple procedure for accurate quantitation of factor VIII inhibitors.
    Tse D; Fekete L; Shanbrom E
    Thromb Diath Haemorrh; 1970 Feb; 23(1):19-25. PubMed ID: 5420431
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemotherapy in blood coagulation disorders].
    Griffitts JJ
    Bibl Haematol; 1967; 27():294-6. PubMed ID: 5317772
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction].
    Richter K; Klingenberg K; Reinecke D
    Z Gesamte Inn Med; 1968 Jan; 23(1):18-21. PubMed ID: 5662427
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood plasma fractions for the treatment of coagulation disorders. II. Production and clinical use of factor VIII containing preparations].
    Richter K
    Z Gesamte Inn Med; 1967 Aug; 22(15):451-6. PubMed ID: 5592694
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfusion therapy in congenital coagulopathies.
    Lusher JM
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1167-80. PubMed ID: 7860443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics and use of blood transfusion and blood components in the treatment of patients with hemostasis disorders: II. Levels of coagulation factors].
    Grgicević D; Pistotnik M
    Lijec Vjesn; 1986 Jun; 108(6):274-7. PubMed ID: 3724356
    [No Abstract]   [Full Text] [Related]  

  • 15. [Directions for blood component therapy in blood coagulation disorders].
    Rasche H
    Klin Anasthesiol Intensivther; 1980; 21():136-51. PubMed ID: 6779052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful treatment of acquired F:VIII C inhibitor after delivery using plasmapheresis and high doses of immunoglobulins].
    Belić A; Pejin D; Canak V; Felle D; Lucić A
    Med Pregl; 1994; 47(9-10):359-61. PubMed ID: 7565328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant.
    Green D; Hougie C; Kazmier FJ; Lechner K; Mannucci PM; Rizza CR; Sultan Y
    Thromb Haemost; 1983 Apr; 49(2):144-6. PubMed ID: 6408752
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statistic considerations in the treatment of patients with coagulation disorders: 2 methods of approach].
    Moro GF; Campolongo F
    Riv Ital Stomatol; 1983; 52(7-8):589-92. PubMed ID: 6236541
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on an acquired anticoagulant directed against factor 8.
    Hougie C
    J Lab Clin Med; 1967 Sep; 70(3):384-92. PubMed ID: 6038544
    [No Abstract]   [Full Text] [Related]  

  • 20. A true hypercoagulability state in patients on chronic hemodialysis.
    Erickson RV; Williman M; Pendras JP
    Trans Am Soc Artif Intern Organs; 1966; 12():205-6. PubMed ID: 5960704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.